Efficacy of Topiramate in Migraine Aura Prophylaxis: Preliminary Results of 12 Patients

Headache

Volumn 44, Issue 2, 2004, Pages 174-176

  Lampl, Christian ^a   Bonelli, Silvia ^a   Ransmayr, Gerhard ^a  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

Aura; Migraine; Prophylaxis; Therapy; Topiramate

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; CALCIUM CHANNEL L TYPE; GLUTAMATE RECEPTOR; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TOPIRAMATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; DISEASE DURATION; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HEADACHE; HUMAN; LONGITUDINAL STUDY; MALE; MEMORY DISORDER; MIGRAINE; MIGRAINE AURA; MORBIDITY; NOCICEPTION; OPEN STUDY; PARESTHESIA; PILOT STUDY; PRIORITY JOURNAL; PROPHYLAXIS; SIDE EFFECT; STATISTICAL ANALYSIS; WEIGHT REDUCTION;

EID: 1242276343     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2004.04036.x     Document Type: Article

References (15)

1. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res. 1997;28:167-179.
2. Cutrer FM. Antiepileptic drugs: how they work in headache. Headache. 2001;41(suppl 1):3-10.
3. Lampl C, Buzath A, Klinger D, Neumann K. Lamotrigine in the prophylactic treatment of migraine aura - a pilot study. Cephalalgia. 1999;19:58-63.
4. D'Andrea G, Granella F, Cadaldini M, Manzoni GC. Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study. Cephalalgia. 1999;19:64-66.
5. Von Seggern RL, Mannix LK, Adelman JU. Efficacy of topiramate in migraine prophylaxis: a retrospective chart analysis. Headache. 2002;42:804-809.
6. Mathew NT, Kailasam J, Meadors L. Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate. Headache. 2002;42:796-803.
7. Young WB, Hopkins MM, Shechter AL, Silberstein SD. Topiramate: a case series study in migraine prophylaxis. Cephalalgia. 2002;22:659-663.
8. Storey JR, Calder CS, Hart DE, Potter DL. Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache. 2001;41:968-975.
9. Freitag F, Silberstein SD, Karim R, Kamin M, Jordan D, Hulihan J. Topiramate prophylaxis in patients suffering from migraine with aura: results from a randomized, double-blind, placebo controlled trial [abstract]. Cephalalgia. 2002;22:579.
10. Post RM, Silberstein SD. Shared mechanisms in affective illness, epilepsy, and migraine. Neurology. 1994;44(suppl 7):37-44.
11. Marrannes R, Willems R, Prins ED, Wauquier A. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat. Brain Res. 1988;457:226-240.
12. Goa KL, Ross SR, Chrisp P. Lamotrigine: a review of its pharmacological properties and clinical efficacy in epilepsy. Drugs. 1993;46:152-176.
13. 2+ currents in cortical neurons: functional implications. Eur J Pharmacol. 1996;307:113-116.
14. Wang SJ, Tsai JJ, Gean PW. Lamotrigine inhibits depolarization-evoked Ca influx in dissociated amygdale neurons. Synapse. 1998;29:355-362.
15. Forderreuther S, Mayer M, Straube A. Treatment of cluster headache with topiramate: effects and side-effects in five patients. Cephalalgia. 2003;23:69-70.